HEALTH OF WOMAN. 2016.2(108):80–86 
 

Изжога беременных: причины и возможности улучшения качества жизни женщин в этот период 
 

Щербинина М. Б., Луговская Т. В., Иванченко Н. А.

Днепропетровский национальный университет имени Олеся Гончара

Центр Планирования семьи Тамары Луговской, г. Днепропетровск 
 

Изжога беременных является серьезной клинической проблемой, так как значительно ухудшает качество жизни женщины. На сегодняшний день общепринятой является гормональная теория возникновения изжоги беременных. Изменение гормонального фона, прогрессирующее увеличение внутрибрюшного давления и феномен постпрандиального кислотного кармана увеличивают вероятность заброса желудочного содержимого в пищевод и развитие изжоги. Современные и безопасные препараты на основе альгиновой кислоты обеспечивают физиологическое антирефлюксное действие, оттесняют книзу кислотный карман, облегчая, таким образом, симптомы рефлюкса у беременных с изжогой.

Ключевые слова: альгинаты, ГЭРБ, изжога у беременных, кислотный карман.

Литература:

1. Mandel KG, Daggy BP, Brodie DA, Jacoby HI. 2000. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment. Pharmacol. Ther. 14:669–690. http://dx.doi.org/10.1046/j.1365-2036.2000.00759.x; PMid:10848650

2. Strugala V, Bassin J еt al. 2012. Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Supressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy. Obstetrics and Gynecology; Article ID 481870: 6, http://dx.doi.org/10.5402/2012/481870.

3. Malfertheiner S, Malfertheiner M, Kropf S. 2012. A prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy. BMC Gastroenterol. 12:131. BMC Gastroenterol. 2012. 12: 131. Published online 2012 Sep 24. http://dx.doi.org/10.1186/1471-230X-12-131.

4. Revicki DA, Wood M, Maton PN et al. 1998. The impact of gastroesophageal reflux disease on health-related quality of life. Am.J. Med. 104:252–258. http://dx.doi.org/10.1016/S0002-9343(97)00354-9

5. Junghard O, Carlsson R, Lind T. 2003. Sufficient control of heartburn in endoscopy-negative gastroesophageal reflux disease trials. Scand. J. Gastroenterol. 38:1197–1199. http://dx.doi.org/10.1080/00365520310004920; PMid:14750636

6. Kahrilas PJ, Shaheen NJ, Vaezi MF et al. 2008. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroentero-logy. 135:1383–1391. http://dx.doi.org/10.1053/j.gastro.2008.08.045; PMid:18789939

7. Katz PO, Gerson LB, Vela MF. 2013, March. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 108:308–328. http://dx.doi.org/10.1038/ajg.2012.444; http://dx.doi.org/10.1038/ajg.2013.314; PMid:23419381

8. Vakil N, van Zanden SV, Kahrilas P et al. 2006. The Monreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus. Am. J. Gastroenterol. 101:1900–1920. http://dx.doi.org/10.1111/j.1572-0241.2006.00630.x; PMid:16928254

9. Fisher RS, Roberts GS, Grabowski CJ, Cohen S. 1978. Altered lower esophageal sphincter function during early pregnancy. Gastroenterology. 74;6:1233–1237. PMid:648814

10. Van Thiel DH, Gavaler JS, Joshi SN et al. 1977. Heartburn of pregnancy. Gastroenterology. 72;4(Pt. 1):666–668.

11. Madanick RD, Katz PO. 2006. GERD and Pregnancy. Practical gastroenterology. 29;6:30–39.

12. Richter JE. 2005. Review article: the management of heartburn in pregnancy. Aliment. Pharmacol. Ther. 22:749–757. http://dx.doi.org/10.1111/j.1365-2036.2005.02654.x; PMid:16225482

13. Van Thiel DH, Gavaler JS, Stremple J. 1976. Lower esophageal sphincter pressure in women using sequential oral contraceptives. Gastroenterology 71;2:232–234. PMid:939383

14. Fletcher J, Wirz A, Young J et al. 2001. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology. 121:775–783. http://dx.doi.org/10.1053/gast.2001.27997; PMid:11606490

15. Clarke AT, Wirz AA et al. 2008. Severe reflux disease is associated with an enlarged unbuffered proximal gastric acid pocket. Gut 57:292-297. http://dx.doi.org/10.1136/gut.2006.109421.

16. Boecxstaens V, Bisschops R et al. 2011. Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. Aliment Pharmacol Ther, 33:1370-1377. http://dx.doi.org/10.1111/j.1365-2036.2011.04664.x; PMid:21517922

17. ASGE Guideline: guidelines for endoscopy in pregnant and lactating women. Gastrointestinal Endoscopy. 2005. 61;3:357–362. http://dx.doi.org/10.1016/S0016-5107(04)02780-4

18. Katz PO, Castell DO. 1998. Gastroesophageal reflux disease during pregnancy. Gastr. Clin. N. Amer. 27:153–167. http://dx.doi.org/10.1016/S0889-8553(05)70351-4

19. Mandel KG, Daggy BP, Brodie DA et al. 2000. Review article alginate raft formulations in the treatment of heartburn and acid reflux. Aliment. Pharmacol. Ther. 14:3–22. http://dx.doi.org/10.1046/j.1365-2036.2000.00759.x

20. Rohof W, Bennink R et al. 2013. An Alginate-Antacid Formulation Localizes to the Acid Pocket to Reduce Acid Reflux in Patients With Gastroesophageal Reflux Disease. Clinical Gastroenterology and Hepatology 11:1585–1591. http://dx.doi.org/10.1016/j.cgh.2013.04.046; PMid:23669304

21. Kwiatek MA, Roman S et al. 2011. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate the postprandial «acid pocket» in symptomatic GERD patients. Aliment. Pharmacol. Ther. 34(1):59–66. http://dx.doi.org/10.1111/j.1365-2036.2011.04678.x; PMid:21535446 PMCid:PMC3612878

22. Strugala V, Dettmar PW, Sarratt K et al. 2010, Mar–Apr. A Randomized, controlled, crossover trial to investigate times to onset of the perception of soothing and cooling by over-the-counter heartburn treatments. J. Int. Med. Res. 38(2):449–457. http://dx.doi.org/10.1177/147323001003800208; PMid:20515559

23. Chatfield S. 1999. A comparison of the efficacy of the alginate preparation Gaviscon Advance, with placebo in the treatment of gastroesophageal reflux disease. Curr. Med. Res. Opin. 15:152–159. http://dx.doi.org/10.1185/03007999909114086; PMid:10621921

24. Lindow SW, Regnell P, Sykes J et al. 2003. An open_label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance) in the treatment of heartburn during pregnancy. Int. J. Clin. Pract. 57(3):175–179. PMid:12723718

25. Uzan M, Uzan S et al. 1988, Jul-Sep. Heartburn and regurgitation in pregnancy. Efficacy and innocuousness of treatment with Gaviscon suspension. Rev Fr Gynecol Obstet. 83(7–9):569–72. PMid:2848305

26. Mandel KG, Deggy BP, Brody DA, Dzheykoby GI. 2010. Al’gynatsoderhashchye preparati v lechenii gastroezofageal’noy reflyuksnoy bolezny. Consilium Medicum. Ukraina. 2:4–8.

27. Dettmar U, Hempson FCh, Toubel D at al. 2008. Podavlenie gastroezofageal’nogo reflyuksa pry pomoshchy al’gynatov. RMZh. Bolezhy organov pyshchevareniya. 10;2:83–86.